Acute tumor lysis syndrome following intrathecal methotrexate

Leukemia and Lymphoma

Volumn 22, Issue 3-4, 1996, Pages 361-363

  Benekli, Mustafa ^a,b   Güllü, Ibrahim H ^a   Savaş, M Cemil ^a   Kadayifçi, Abdurrahman ^a   Altundaǧ, M Kadri ^a   Tekuzman, Gülten ^a   Firat, Dinçer ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Intrathecal methotrexate; Lymphoblastic lymphoma; Meningeal involvement; Tumor lysis syndrome

Indexed keywords

METHOTREXATE;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG CYTOTOXICITY; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LYMPHOBLASTOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MENINX; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0029816705     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609051770     Document Type: Article

References (8)

1. Arrambide, K. and Toto, R. D. (1993) Tumor lysis syndrome. Semin. Nephrol., 309, 1094-1104.
2. Benekli, M., Savas , M. C., Güllü, I. H., Kadayifçi, A., Akpek, G., Kars, A., Güler, N., Kansu, E., Tekuzman, G. and Firat, D. (1995) Tumor lysis syndrome following single dose mitoxantrone. Chemotherapy, 41, 470-472.
3. Sparano, J., Ramirez, M. and Wiernik, P. H. (1990) Increased recognition of corticosteroid induced tumor lysis syndrome in non-Hodgkin's lymphoma. Cancer, 65, 1072-1073.
4. Simmons, E. D. and Somberg, K. A. (1991) Acute tumor lysis syndrome after intrathecal methotrexate administration. Cancer, 67, 2062-2065.
5. Shapiro, W. R., Young, D. R. and Mehta, B. M. (1975) Distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N. Engl. J. Med., 293, 161-166.
6. Bode, U., Magrath, I. T., Bleyer, W. A., Poplack, D. G. and Glaubiger, D. L. (1980) Active transport of methotrexate from cerebrospinal fluid in humans. Cancer Res., 40, 2184-2187.
7. Jolivet, J., Cowan, K. H., Curt, G. A., Cleadeninn, N. J. and Chabner, B. A. (1983) The pharmacology and clinical use of methotrexate. N. Engl. J. Med., 309, 1094-1104.
8. Bleyer, W. A., Drake, J. C. and Chabner, B. A. (1973) Neurotoxicity and elevated cerebrospinal fluid methotrexate concentration in meningeal leukemia. N. Engl. J. Med., 289, 770-773.